Company intelligence / Profile preview

Metabolic Technologies

Ames, Iowa, United States

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Metabolic Technologies has brought to market clinically proven ingredients, beginning with HMB (myHMB), which has shown safety and efficacy across more than 50 clinical studies for muscle health and function in various populations including athletes and the elderly. Newer formulations (myHMB Clear, myHMB + Vitamin D, and myHMB Clear + PEAK ATP) have evidence of enhanced performance and safety from published human trials.

Therapeutic areas: NeurologyRheumatologyMetabolic DisordersOther
Modalities: Small moleculeNutritional ingredient
Industry: Food & Nutrition

Partnerships

TSI Group Ltd. (co-development and commercial partnership for myHMB Clear + PEAK ATP)

Beyond the preview

Go deeper on Metabolic Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Metabolic Technologies.

Explore the full profile